Launch week offerEnds in00h00m00s

annual Promonthly Pro

Natalia Kulesskaya

Head of Non-clinical Pharmacology

Finland

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Finland

Articles (12)

Year:

2026

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (12)

Andrey Abramov

University College London

UNITED KINGDOM

View details

Mikko Airavaara

University of Helsinki

FINLAND

View details

Noemí Esteras

Ramón y Cajal Senior Research Fellow

Universidad Complutense de Madrid

SPAIN

View details

Anastasia Ludwig

University of Helsinki

FINLAND

View details

Henri Huttunen

University of Helsinki

FINLAND

View details

Vassilis Stratoulias

University of Helsinki

FINLAND

View details

Marta Saez Garcia

University of Helsinki

FINLAND

View details

Maria Lindahl

University of Helsinki

FINLAND

View details

J. Arturo García-Horsman

University of Helsinki

FINLAND

View details

Kira Holmström

Head of Biomarker Research

FINLAND

View details

Rimante Minkeviciene

University of Helsinki

FINLAND

View details

Hjalmar Bjartmarz

Head of Stereotactic and Functional Neurosurgery

Region Skåne

SWEDEN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Natalia Kulesskaya

Research Interests

Make your next move.

Explore related searches

Articles (12)

Cerebral dopamine neurotrophic factor and its functional fragments induce calcium signal through sigma-1 receptor and protect neurons against glutamate-induced excitotoxicity

Brain-penetrating neurotrophic factor mimetics: HER-096 as a disease-modifying therapy for Parkinson’s disease

Structural basis of CDNF interaction with the UPR regulator GRP78

HER-096 is a CDNF-derived brain-penetrating peptidomimetic that protects dopaminergic neurons in a mouse synucleinopathy model of Parkinson’s disease

Intraputamenal Cerebral Dopamine Neurotrophic Factor in Parkinson's Disease: A Randomized, Double‐Blind, Multicenter Phase 1 Trial

Augmenting hematoma-scavenging capacity of innate immune cells by CDNF reduces brain injury and promotes functional recovery after intracerebral hemorrhage

Low-Molecular Weight Protamine Overcomes Chondroitin Sulfate Inhibition of Neural Regeneration

Protective Role of Low Ethanol Administration Following Ischemic Stroke via Recovery of KCC2 and p75NTR Expression

Heparin-Binding Growth-Associated Molecule (Pleiotrophin) Affects Sensory Signaling and Selected Motor Functions in Mouse Model of Anatomically Incomplete Cervical Spinal Cord Injury

Elevated expression of endogenous glial cell line-derived neurotrophic factor impairs spatial memory performance and raises inhibitory tone in the hippocampus

The circadian gene Cryptochrome 2 influences stress-induced brain activity and depressive-like behavior in mice

Kainate Receptor Auxiliary Subunit NETO2-Related Cued Fear Conditioning Impairments Associate with Defects in Amygdala Development and Excitability

Collaborators (12)

Andrey Abramov

Mikko Airavaara

Noemí Esteras

Anastasia Ludwig

Henri Huttunen

Vassilis Stratoulias

Marta Saez Garcia

Maria Lindahl

J. Arturo García-Horsman

Kira Holmström

Rimante Minkeviciene

Hjalmar Bjartmarz

Make your next move.